Skip to main content

View full-text article in PMC

. 2023 Sep 27;15(9):1950–1958. doi: 10.4240/wjgs.v15.i9.1950

Table 3.

Comparative analyses for inflammatory factors levels pre-/post-therapy in all cohorts (x ± s)

Cohort	CRP (mg/L)		TNF-α (ng/L)		IL-6 (ng/L)		MCP-1 (ng/L)
Cohort	Pre-therapy	Post-therapy	Pre-therapy	Post-therapy	Pre-therapy	Post-therapy	Pre- therapy	Post-therapy
Cohort A (n = 20)	32.84 ± 3.90	17.14 ± 2.27^a^,^b^,^c	10.11 ± 1.74	2.62 ± 0.83^a^,^b^,^c	34.92 ± 2.31	15.27 ± 1.15^a^,^b^,^c	213.33 ± 14.91	122.91 ± 19.00^a^,^b^,^c
Cohort B (n = 20)	34.40 ± 4.67	19.99 ± 3.51^a^,^c	11.03 ± 1.99	3.79 ± 1.06^a^,^c	35.59 ± 1.59	18.88 ± 1.58^a^,^c	215.24 ± 19.15	150.74 ± 19.76^a^,^c
Cohort C (n = 20)	32.27 ± 2.78	25.16 ± 2.41^a	10.80 ± 2.06	5.35 ± 0.95^a	34.92 ± 3.09	23.43 ± 2.26^a	211.07 ± 16.46	167.83 ± 15.10^a
F value	1.636	42.566	1.227	41.469	0.526	112.506	0.303	31.482
P value	0.204	< 0.001	0.301	< 0.001	0.594	< 0.001	0.740	< 0.001

^a

Indicated P < 0.05 when compared with the same cohort pre-therapy.

^b

Indicated P < 0.05 when compared with cohort B.

^c

Indicated P < 0.05 when compared with cohort C.

CRP: C-reactive protein; TNF-α: Tumor necrosis factor-alpha; IL-6: Interleukin-6; MCP-1: Monocyte chemoattractant protein-1.